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Sir,
With great interest, we read the recent article by Kindzelski et al. 1 assessing the association between intraoperative blood product transfusions and acute kidney injury (AKI) following cardiac surgery. By binary logistic regression analysis, they show that intraoperative blood product transfusions are independently associated with an increased risk of postoperative AKI. Furthermore, there is a stepwise increase in the probability of postoperative 30-day mortality with escalating AKI severity. In this study, the authors had used appropriate statistical methods to evaluate the influence of intraoperative blood transfusion on the occurrence of AKI and determine the association between postoperative AKI stages and mortality. However, this study is a retrospective analysis, which potentially introduces a number of confounders. Other than the limitations described in the discussion, we note that several issues of this study were not well addressed.
First, when determining the association of intraoperative blood transfusion with postoperative AKI stages by logistic regression analysis, intraoperative variables used for risk adjustments only included type of surgery (CABG, valvular, both) and cross-clamp time, but not other important intraoperative variables associated with AKI, especially for hemoglobin levels during cardiopulmonary bypass. It has been shown that hemodilution anemia during cardiopulmonary bypass is independently associated with AKI after cardiac surgery, especially when prolonged cardiopulmonary bypass time and intraoperative transfusion are needed. 2 Furthermore, the simultaneous occurrence of both hemodilution anemia and hypotension during cardiopulmonary bypass can synergistically act to increase the risk of AKI after cardiac surgery. 3 We are concerned that the neglect of important intraoperative factors for risk adjustments would have biased the true contribution of intraoperative blood transfusion to the occurrence of postoperative AKI.
Second, this study only focused on the influence of intraoperative blood transfusion on the development of postoperative AKI. The available evidence shows that blood transfusion after cardiac surgery is also an independent risk factor of postoperative AKI. 4, 5 Finally, when evaluating the association of escalating AKI severity with postoperative 30-day mortality by logistic regression analysis, postoperative anemia and blood transfusion were not included in the model for risk adjustment. Similarly, postoperative blood transfusion has also been associated independently with the increased risk of adverse events and mortality after cardiac surgery. 6 Furthermore, postoperative anemia is common and frequently persists for months after cardiac surgery. When the postoperative hemoglobin level is considered as a continuous variable, every 1 mg/dl decrease in hemoglobin level is associated with a 13% increase in adverse cardiovascular events and a 22% increase in all-cause mortality. 7 Thus, not taking postoperative anemia and blood transfusion into account would have tampered with the inference of the logistic regression model for adjusted impacts of AKI stages on postoperative 30-day mortality.
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